A-Rod received therapeutic use exemptions for testosterone for several seasons before Biogenesis hit

41 Comments

There’s a book coming out soon about the Biogenesis scandal. It’s called “Blood Sport: Alex Rodriguez, Biogenesis and the Quest to End Baseball’s Steroid Era” by Tim Elfrink of the Miami New Times and Gus Garcia-Roberts of Newsday. Sports Illustrated is running a very tasty excerpt from it today.

The subject: Alex Rodriguez, not surprisingly. And while part of it is sexy — apparently, the first words out of A-Rod’s mouth to Tony Bosch were “What were you giving Manny Ramiez?” — there’s a more significant and more interesting part of it all too. Specifically: about the many therapeutic use exemptions A-Rod received to legally take testosterone before he hooked up with Biogenesis.

Therapeutic Use Exemptions — or TUEs as they’re often called — allow players to take otherwise banned drugs if they demonstrate a medical need to do so. These days we hear about them most often in connection with stimulants like Adderall, which are used to treat attention deficit disorder. Of course, a far greater percentage of players in Major League Baseball have therapeutic use exemptions for ADD medicine than the population at large has ADD, and for this reasons many look at the TUEs given for them with suspicion. As a means of players to obtain performance enhancing drugs without having to worry about being suspended.

In the book excerpt we learn that A-Rod received multiple TUEs during his time with the Yankees. But they weren’t for ADD medication. They were for testosterone, which is a really damn rare exemption to get. But A-Rod got it:

Before the 2007 season, Rodriguez asked for permission to use testosterone, which has been banned by baseball since 2003. The IPA in ’07 was Bryan W. Smith, a High Point, N.C., physician. (Baseball did not yet have the advisory medical panel.) On Feb. 16, 2007, two days before Rodriguez reported to spring training, Smith granted the exemption, allowing Rodriguez to use testosterone all season.

A-Rod won the MVP that year and, at the end of the year, famously opted out of his Yankees deal and signed his ten-year contract extension. Even after securing what he had to know was his last professional contract, A-Rod continued to apply for and receive TUEs. In 2008 he received a TUE for Clomid, which is similar to the drug that Manny Ramirez got busted for when he was with the Dodgers. A-Rod took it with Major League Baseball’s approval, however.

I’d be pretty interested to learn more about those TUEs A-Rod got. Why he got them when, apparently, a lot of people didn’t. Whether MLB believes it had been too permissive with them back then and whether A-Rod’s decision to quit relying on those and, instead, go an illegal route with Tony Bosch, angered them in some way. I’d also be curious to know if there is a psychological dependency at work with testosterone and other such drugs and whether Major League Baseball approving A-Rod’s use of the stuff contributed to whatever it was that drove A-Rod to continue to take PEDs, long after he ceased to have much if anything to prove on a baseball diamond.

2017 Preview: The American League Central

Getty Images
1 Comment

For the past few weeks we’ve been previewing the 2017 season. Here, in handy one-stop-shopping form, is our package of previews from the American League Central

Do the Indians have a weakness? Do the Tigers and Royals have one more playoff push in them or do they have to start contemplating rebuilds? The White Sox and Twins are rebuilding, but do either of them have a chance to be remotely competitive?

As we sit here in March, the answers are “not really,” “possibly,” and “not a chance.” There are no games that count this March, however, so they’re just guesses. But educated ones! Here are the links to our guesses and our education for all of the clubs of the AL Central:

Cleveland Indians
Detroit Tigers
Kansas City Royals
Chicago White Sox
Minnesota Twins

2017 Preview: The National League East

Getty Images
2 Comments

For the past few weeks we’ve been previewing the 2017 season. Here, in handy one-stop-shopping form, is our package of previews from the National League East

The Washington Nationals crave a playoff run that doesn’t end at the division series. The Mets crave a season in which they don’t have a press conference about an injured pitcher. The Marlins are trying to put the nightmare of the end of the 2016 behind them. The Phillies and Braves are hoping to move on from the “lose tons of games” phase of their rebuilds and move on to the “hey, these kids can play!” phase.

There is a ton of star power in the NL East — Harper, Scherzer, Cespedes, Syndergaard, Stanton, Freeman — some great young talent on ever roster and, in Ichiro and Bartolo, the two oldest players in the game. Maybe the division can’t lay claim to the best team in baseball, but there will certainly be some interesting baseball in the division.

Here’s how each team breaks down:

Washington Nationals
New York Mets
Miami Marlins
Philadelphia Phillies
Atlanta Braves